The Efficacy of Caralluma for Anxiety in Adults

Not Applicable

Completed

• Conditions: Anxiety; Stress; Mental Health - Anxiety; Alternative and Complementary Medicine - Herbal remedies

• Registration Number: ACTRN12616000741482
• Lead Sponsor: RDC Global

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-06-06
• Study Completion: 2017-05-12
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 117

Inclusion Criteria

Participants will be included for assessment if they self-report mild-moderate anxiety (BAI >9<30), are not diagnosed with depression or a mood disorder, are otherwise healthy, and have given written informed consent.

Exclusion Criteria

Participants will be excluded if they:
have a known hypersensitivity to herbal drugs, or nutritional supplements;
have been diagnosed with hypertension and are receiving medication;
have a medical condition which, in the opinion of the investigator, makes them unsuitable or deemed unhealthy (including a BMI > 30);
have currently or have a history of chronic alcohol and/or drug abuse;
have participated in any other clinical trial during last 30 days;
are currently participating in another clinical trial;
have been diagnosed with a mood disorder;
have minimal or severe anxiety on the Beck Anxiety Inventory (<10, or > 29);
suffered severe PMS with mood or pain that would change during the study;
suffered from any neurological disorder;
are taking supplements that impact mood or appetite (e.g., St John’s Wort, leptin);
are already taking Caralluma.

Study & Design

• Study Type: Interventional
• Study Design: Not specified